Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Autism|August 5, 2017
A brain proteomic investigation of rapamycin effects in the Tsc1+/- mouse modelHendrik Wesseling, Ype Elgersma, Sabine Bahn
The International Journal of Neuropsychopharmacology|December 25, 2014
Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disordersHendrik Wesseling, Michael G Gottschalk, Sabine Bahn
The International Journal of Neuropsychopharmacology|February 15, 2014
Technological advances for deciphering the complexity of psychiatric disorders: merging proteomics with cell biologyHendrik Wesseling, Paul C Guest, Santiago G Lago, et al.
The International Journal of Neuropsychopharmacology|January 23, 2015
Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolismMichael G Gottschalk, Hendrik Wesseling, Paul C Guest, et al.
Applied and Environmental Microbiology|March 24, 2009
Exopolyphosphatases PPX1 and PPX2 from Corynebacterium glutamicumSteffen N Lindner, Sandra Knebel, Hendrik Wesseling, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 28, 2016
Evaluation of molecular brain changes associated with environmental stress in rodent models compared to human major depressive disorder: A proteomic systems approachDavid Alan Cox, Michael Gerd Gottschalk, Viktoria Stelzhammer, et al.
Schizophrenia Research|June 24, 2016
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathologyDavid A Cox, Michael G Gottschalk, Hendrik Wesseling, et al.
Pageof 3